| [1] | Huijuan FAN, Chun SONG. Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(1): 128-136. doi: 10.3969/j.issn.1001-5256.2023.01.019 |
| [2] | Chuanfu QIN, Yali ZHAO, Lijuan LONG, Hua QIU. Mechanism of cytotoxic T lymphocyte－derived exosomes inhibiting hepatic stellate cell activation[J]. Journal of Clinical Hepatology, 2023, 39(10): 2340-2347. doi: 10.3969/j.issn.1001-5256.2023.10.011 |
| [3] | Hepatology International｜Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial[J]. Journal of Clinical Hepatology, 2023, 39(10): 2431-2431. doi: 10.3969/j.issn.1001-5256.2023.10.gwjpwzjj1 |
| [4] | Mengkui HAN, Jin LI, Xiaohua YANG. Function and regulatory mechanism of T lymphocytes in tumor immune microenvironment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2621-2626. doi: 10.3969/j.issn.1001-5256.2022.11.037 |
| [5] | Huili WU, Hongbo SHI, Yanmin LIU, Yan YAN, Lingling WANG, Mei DING, Zhenglai MA, Hui LIU, Zhongping DUAN. Expression of autophagy marker in peripheral blood T and B lymphocytes of patients with autoimmune hepatitis and its clinical significance[J]. Journal of Clinical Hepatology, 2022, 38(11): 2483-2487. doi: 10.3969/j.issn.1001-5256.2022.11.009 |
| [6] | Xiaofei YANG, Huanjun SHEN, Gaobo HUANG, Jianqi LIAN, Ye ZHANG. Changes and clinical significance of natural killer-like B cells, natural killer cells, and B cells in peripheral blood of patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2022, 38(7): 1489-1494. doi: 10.3969/j.issn.1001-5256.2022.07.008 |
| [7] | Guangjun TANG, Jing YOU, Huai'e LIU, Yujuan PENG. Role of T helper 17 cell/regulatory T cell imbalance in the progression of HBV-related liver diseases[J]. Journal of Clinical Hepatology, 2021, 37(2): 414-418. doi: 10.3969/j.issn.1001-5256.2021.02.035 |
| [8] | Liu XiaoJu, Zhang Zheng. Functional cure of chronic hepatitis B from the perspective of specific immune cells for hepatitis B virus[J]. Journal of Clinical Hepatology, 2020, 36(5): 977-979. doi: 10.3969/j.issn.1001-5256.2020.05.004 |
| [9] | Zhao JinHua, Li JunFeng, Mao XiaoRong. Effect of T-lymphocyte phenotype on immune status in chronic hepatitis B virus infection and its application value[J]. Journal of Clinical Hepatology, 2020, 36(5): 1019-1023. doi: 10.3969/j.issn.1001-5256.2020.05.014 |
| [10] | JIN Juan, HUANG XiaoZheng, JING XinYan, ZHANG Yuan, YIN JinLing, LI JiaJia, WANG SiSi, GUO YaLing, LI Ying. Change and significance of HBcAg-specific Th22 cells in patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2020, 36(11): 2435-2440. doi: 10.3969/j.issn.1001-5256.2020.11.008 |
| [11] | Wang HaoLiang, Deng GuoHong. Functional status of hepatitis B virus-specific T cells in patients with chronic hepatitis B virus infection:Exhausted or silenced?[J]. Journal of Clinical Hepatology, 2020, 36(5): 980-982. doi: 10.3969/j.issn.1001-5256.2020.05.005 |
| [13] | Ge KuanXue, Gao WeiHua, Xiang XiaoXing. Association of regulatory T cells, T helper 17 cells, and change in their balance with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(7): 1573-1576. doi: 10.3969/j.issn.1001-5256.2018.07.045 |
| [14] | Yin SiHan, Liu Peng, Zhang Tao, Sun KeWei. Analysis of TCM deficiency and excess attributes in patients with HBV- related acute- on- chronic liver failure based on phenotype of dendritic cells and function of T lymphocytes[J]. Journal of Clinical Hepatology, 2016, 32(4): 663-668. doi: 10.3969/j.issn.1001-5256.2016.04.010 |
| [15] | He JunNan, Zhao ShouSong. Research advances in association between regulatory T cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2016, 32(2): 361-365. doi: 10.3969/j.issn.1001-5256.2016.02.036 |
| [16] | Zhou Yan, Jing Xiang, Zhu ZhengYan. Roles of regulatory T cells and T-helper cells in hepatitis B virus-related liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(10): 1994-1997. doi: 10.3969/j.issn.1001-5256.2016.10.040 |
| [17] | Hou YuLi, Zhang YongHong, Zhao Yan. Immunological characteristics of tumor antigen specific T cells and their possible mechanisms in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(6): 1220-1224. doi: 10.3969/j.issn.1001-5256.2016.06.048 |
| [18] | Cheng Ping, Xue BoYu. Research progress in Treg/Th17 imbalance in persistent HBV infection[J]. Journal of Clinical Hepatology, 2015, 31(4): 603-606. doi: 10.3969/j.issn.1001-5256.2015.04.031 |
| [19] | Li CaiDong, Chen XiLian, Tian PengFei, Li HuiJun, Wu Bin. Correlation analysis of percentages of T lymphocyte subsets and CD4~+CD25~+ regulatory T cells and HBV DNA level in peripheral blood of chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2015, 31(4): 541-545. doi: 10.3969/j.issn.1001-5256.2015.04.016 |
| [20] | Peng JianPing, Sun KeWei, Wu YuNan, Zhang QianQian. Programmed cell death 1 expression on HBV-specific CTLs induced by dendritic cells in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 926-929. |
DownLoad: